CDSCO Approves Aurobindo CuraTeQ's Bevacizumab Biosimilar Bevqolva for Cancer Treatment Written By Parthika Patel17 May 2026 10:22 PM ISTNew Delhi: Aurobindo Pharma on Friday announced that its wholly owned subsidiary CuraTeQ Biologics Pvt Ltd has received marketing authorisation from...
Aurobindo Arm CuraTeQ Clears Key CDSCO Hurdle for Bevacizumab Cancer Biosimilar Written By Parthika Patel10 May 2026 10:00 AM ISTNew Delhi: CuraTeQ Biologics Private Limited has received recommendation from the Subject Expert Committee (SEC), CDSCO, for grant of permission to...
Aurobindo Arm CuraTeQ Secures Health Canada Nod for Cancer Biosimilar Bevqolva Written By sheeba farhat4 May 2026 11:00 PM ISTNew Delhi: Aurobindo Pharma on Friday said its arm CuraTeQ Biologics has received a compliance notice from Health Canada's Biologics and...
Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe Written By Parthika Patel26 March 2026 11:53 PM ISTHyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has entered into a marketing and...
Aurobindo Arm CuraTeQ Gets Health Canada NOC for Pegfilgrastim Biosimilar Dyrupe Written By Farhat Nasim9 Jan 2026 11:36 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a Notice of Compliance (NOC) from...
Aurobindo Pharma arm terminates Ustekinumab biosimilar pact with BioFactura Written By Ruchika Sharma27 Dec 2025 6:06 PM ISTHyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of the Company, has mutually agreed to...
Aurobindo Pharma arm CuraTeQ Biologics incorporates new wholly owned subsidiary in Malta Ruchika Sharma27 Sept 2025 4:51 PM ISTHyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics B.V., a wholly owned step-down subsidiary of the Company, has incorporated a...
Aurobindo Pharma's subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys in HER2-Positive Cancer Farhat Nasim26 Aug 2025 2:26 PM ISTHyderabad: CuraTeQ Biologics, a wholly owned step-down subsidiary of Aurobindo Pharma Ltd., has secured marketing authorisation from the UK's...
Aurobindo Pharma arm gets marketing nod for Dazublys from European Commission Ruchika Sharma2 July 2025 5:33 PM ISTHyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics, a wholly owned step-down subsidiary of the company, has obtained marketing...
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg Written By Ruchika Sharma24 Jun 2025 5:49 PM ISTHyderabad: Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the...
Aurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands Ruchika Sharma29 May 2025 4:56 PM ISTHyderabad: Aurobindo Pharma has announced that Curateq Biologics Private Limited, a wholly owned subsidiary of the Company, has incorporated a...
Aurobindo Pharma arm gets marketing authorisation in UK for Zefylti Written By Ruchika Sharma14 May 2025 11:41 AM ISTHyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing authorisation from UK’s...
